We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTO Upholds Shire Patent for Elaprase Enzyme Replacement Therapy
PTO Upholds Shire Patent for Elaprase Enzyme Replacement Therapy
The PTO’s Patent Trial and Appeal Board upheld Shire’s patent claims — following a challenge from Green Cross — over methods for the manufacture of Elaprase (idursulfase), an enzyme replacement therapy for Hunter syndrome.